“Pfizer made $US 19 Billion in Q2 this year, or $211 million per day. Some known risks of their jab are blood clots and cardiomyopathy. Luckily for them they make Eliquis for treating blood clots – sales up 13%. They also make Vyndaqel to treat cardiomyopathy – sales are up 77%!”

Now we know what this is really all about.